| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790262 | Urologic Oncology: Seminars and Original Investigations | 2017 | 5 Pages |
Abstract
In our study cohort, the multiple use of HAL-TUR-BT within the same patient caused no major side effects or an induction of allergization against the substance. We, therefore, conclude that HAL-TUR-BT can be performed safely in the same patient during the follow-up of aggressive tumors as recommended by different guidelines today.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Maria M.D., Tobias M.D., Alexander M.D., Alexander M.D., Birte-Swantje M.D., Friedrich M.D., Markus M.D., Gerald M.D., Christian G. M.D., Ph.D., Alexander M.D.,